News
press releaseS
American Pharmacists Association Foundation, NOWDiagnostics Launch Nationwide In-Pharmacy Real-Time COVID-19 Antibody Testing with Spike Protein-Targeted, Rapid ADEXUSDx® Test
SPRINGDALE, ARK., July 19, 2021 – The American Pharmacists Association Foundation (APhA Foundation) and NOWDiagnostics, Inc., a Springdale-based leader in innovative diagnostics testing, today announced
University of Arkansas, NOWDiagnostics Partner for COVID-19 Antibody Test and Prevalence Study
SPRINGDALE, Ark., June 16, 2021 /PRNewswire/ — The University of Arkansas and NOWDiagnostics, Inc., a Springdale-based leader in innovative diagnostics testing, announced today an active
ADEXUSDx® COVID-19 Antibody Test Receives FDA Emergency Use Authorization for Point-of-Care Deployment Across U.S.
SPRINGDALE, AR, May 26, 2021 – NOWDiagnostics, Inc. announced today that it has received Emergency Use Authorization (EUA) for its ADEXUSDx® COVID-19 antibody test for use
FDA Grants Emergency Use Authorizations for SARS-CoV-2 Tests From Harvard, NowDiagnostics
NEW YORK — The US Food and Drug Administration has granted separate Emergency Use Authorizations for a molecular SARS-CoV-2 test developed by Harvard University and
Self-Contained, Rapid ADEXUSDx® COVID-19 Antibody Fingerstick Test Receives CE Mark for Deployment Across European Union
SPRINGDALE, AR, December 17, 2020 – Effective December 8, 2020, NOWDiagnostics, Inc. has received Conformité Européene (CE) mark approval for its ADEXUSDx® COVID-19 ‘antibody fingerstick’
ADEXUSDx® COVID-19 Antibody Test Filed for Point of Care Emergency Use Authorization
SPRINGDALE, Ark., Dec. 10, 2020 /PRNewswire/ — NOWDiagnostics, Inc. announced today that it has filed for expanded Emergency Use Authorization (EUA) from the U.S. Food and Drug Administration (FDA)